SP-8203
- Generic Name
- SP-8203
- Drug Type
- Small Molecule
- Chemical Formula
- C28H34N6O5
- CAS Number
- 1176758-04-5
- Unique Ingredient Identifier
- UYE03B60KA
- Background
SP-8203 has been used in trials studying the treatment of Ischemic Stroke.
Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care
- First Posted Date
- 2024-10-28
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 852
- Registration Number
- NCT06660719
- Locations
- π°π·
Dong-A University Hospital, Busan, Korea, Republic of
π°π·Ulsan University Hospital, Ulsan, Korea, Republic of
Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2023-03-08
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 178
- Registration Number
- NCT04479449
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
Phase 2
Completed
- Conditions
- Ischemic Stroke
- Interventions
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT02787278
- Locations
- π°π·
Pusan National University Hospital, Busan, Korea, Republic of
π°π·Asan Medical Center, University of Ulsan, Seoul, Korea, Republic of
π°π·Kyungpook National University Hospital, Daegu, Korea, Republic of
Safety, Tolerability and Pharmacokinetics of SP-8203
- First Posted Date
- 2012-12-31
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT01757795
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath